StockData
Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc. (XENE) stock

XENENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$38.78−0.48 (-1.22%)

Close on Nov 17, 2026Market cap $3.76BP/E –Yield –

Xenon Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Xenon Pharmaceuticals's pe ratio was 7.3× on Oct 30, 2015.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2015Oct 30, 20157.3×+2.2
2014Dec 31, 20145.1×–

More Xenon Pharmaceuticals figures

See a number that looks wrong?